Both compounds have been individually studied for their potential to accelerate healing and reduce inflammation
Clinical trials have demonstrated a 65 percent reduction in vertebral fracture risk and a 35 to 53 percent reduction in non-vertebral fracture risk after 20 months of treatment at 20 micrograms per day
For over two decades, our formulations have leveraged the unique regenerative power of copper-binding tripeptides to address aging, photodamage, and compromised barrier function at the cellular level
The Certificate of Analysis confirms purity, verifies molecular identity, and carries a unique batch number for full traceability
It was first isolated and characterized by researchers at the University of Zagreb in the 1990s and has since been studied extensively in animal models
**Neurological Disorders:** Supportive treatment in certain neurological disorders associated with vitamin B12 deficiency, such as peripheral neuropathy